Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy

E-ISSN： 1875-6115|12|3|224-235

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.12, Iss.3, 2012-07, pp. : 224-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Co-stimulation agonists as a new immunotherapy for autoimmune diseases

By Sun Y. Subudhi S.K. Fu Y.-X.

Trends in Molecular Medicine, Vol. 9, Iss. 11, 2003-11 ,pp. : 483-489

Elsevier

Access to resources Recommend Favorite

Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer

By Hombach Andreas A Abken Hinrich

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 677-681

Future Medicine

Access to resources Recommend Favorite

BAFF production by antigen‐presenting cells provides T cell co‐stimulation

By Huard Bertrand

International Immunology, Vol. 16, Iss. 3, 2004-03 ,pp. : 467-475

Oxford University Press

Access to resources Recommend Favorite

LFA-1 co-stimulation inhibits T h 2 differentiation by down-modulating IL-4 responsiveness

By Jenks Scott A.

International Immunology, Vol. 17, Iss. 3, 2005-03 ,pp. : 315-323

Oxford University Press

Access to resources Recommend Favorite

Striving for synergy: how to improve cancer immunotherapy through multiple agonist costimulation

By Adler Adam J Vella Anthony T

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1271-1273

Future Medicine

Access to resources Recommend Favorite